106 related articles for article (PubMed ID: 2325571)
21. Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.
Dechant KL; Goa KL
Drugs Aging; 1994 Oct; 5(4):300-17. PubMed ID: 7827399
[TBL] [Abstract][Full Text] [Related]
22. Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D
Liao EY; Zhang ZL; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; Peng YD; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L
BMC Musculoskelet Disord; 2018 Jul; 19(1):210. PubMed ID: 29970059
[TBL] [Abstract][Full Text] [Related]
23. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
Cosman F; Nieves J; Shen V; Lindsay R
J Bone Miner Res; 1995 Apr; 10(4):594-600. PubMed ID: 7610930
[TBL] [Abstract][Full Text] [Related]
24. Calcitriol and postmenopausal osteoporosis.
Sambrook P
Med J Aust; 1992 Sep; 157(6):364-6. PubMed ID: 1447982
[No Abstract] [Full Text] [Related]
25. VDR genotype and response to etidronate therapy in late postmenopausal women.
Marc J; Prezelj J; Komel R; Kocijancic A
Osteoporos Int; 1999; 10(4):303-6. PubMed ID: 10692979
[TBL] [Abstract][Full Text] [Related]
26. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
27. The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.
Caniggia A; Nuti R; Loré F; Vattimo A
J Endocrinol Invest; 1984 Aug; 7(4):373-8. PubMed ID: 6094649
[TBL] [Abstract][Full Text] [Related]
28. Clodronic acid in the treatment of postmenopausal osteoporosis.
Tanakol R; Yarman S; Bayraktaroglu T; Boztepe H; Alagöl F
Clin Drug Investig; 2007; 27(6):419-33. PubMed ID: 17506592
[TBL] [Abstract][Full Text] [Related]
29. Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
Malavolta N; Zanardi M; Veronesi M; Ripamonti C; Gnudi S
Int J Tissue React; 1999; 21(2):51-9. PubMed ID: 10568224
[TBL] [Abstract][Full Text] [Related]
30. 1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover.
Need AG; Horowitz M; Philcox JC; Nordin BE
Miner Electrolyte Metab; 1985; 11(1):35-40. PubMed ID: 3838358
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D for the treatment of osteoporosis.
Nakamura T
Osteoporos Int; 1997; 7 Suppl 3():S155-8. PubMed ID: 9536323
[No Abstract] [Full Text] [Related]
32. Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate.
Gallagher JC; Riggs BL
Metabolism; 1990 Apr; 39(4 Suppl 1):30-4. PubMed ID: 2325569
[TBL] [Abstract][Full Text] [Related]
33. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
[TBL] [Abstract][Full Text] [Related]
34. Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss.
Heikkinen JE; Selander KS; Laitinen K; Arnala I; Väänänen HK
J Bone Miner Res; 1997 Jan; 12(1):103-10. PubMed ID: 9240732
[TBL] [Abstract][Full Text] [Related]
35. Calcitriol load test in postmenopausal osteoporosis: a pilot study.
Stefikova K; Spustova V; Krivosikova Z; Dzurik R
Bratisl Lek Listy; 2004; 105(5-6):211-4. PubMed ID: 15535112
[TBL] [Abstract][Full Text] [Related]
36. Role of calcitriol in prevention of osteoporosis: Part I.
Drezner MK; Nesbitt T
Metabolism; 1990 Apr; 39(4 Suppl 1):18-23. PubMed ID: 2325566
[TBL] [Abstract][Full Text] [Related]
37. Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis.
Pietschmann P; Resch H; Krexner E; Woloszczuk W; Willvonseder R
Acta Med Austriaca; 1991; 18(5):114-6. PubMed ID: 1796722
[TBL] [Abstract][Full Text] [Related]
38. 1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women.
Duda RJ; Kumar R; Nelson KI; Zinsmeister AR; Mann KG; Riggs BL
J Clin Invest; 1987 Apr; 79(4):1249-53. PubMed ID: 3494046
[TBL] [Abstract][Full Text] [Related]
39. Treatment of osteoporosis with vitamin D.
Kanis JA; McCloskey EV; de Takats D; Bernard J; Zhang DM
Osteoporos Int; 1997; 7 Suppl 3():S140-6. PubMed ID: 9536320
[No Abstract] [Full Text] [Related]
40. Calcitriol in the treatment of postmenopausal osteoporosis.
Aloia JF; Vaswani A; Yeh JK; Ellis K; Yasumura S; Cohn SH
Am J Med; 1988 Mar; 84(3 Pt 1):401-8. PubMed ID: 3279769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
